Bitcoin Depot heads into its May 14 earnings call carrying the heaviest disclosure weight it has ever faced — a going-concern warning issued on the same day it pre-announced a near-halving of quarterly revenue.
Tuesday's pre-announcement was blunt. Q1 2026 revenue came in at $80.7 million, down 49.2% year-over-year. Management disclosed a $9.5 million net loss and confirmed that material weaknesses flagged in the 2025 annual report remain unresolved. The company also revealed it has accrued over $20 million in legal judgments tied to Q4 2025 litigation. Most critically, management stated substantial doubt about going-concern status and said it is evaluating restructuring, refinancing, asset sales, and other strategic actions. That is as loaded a set of disclosures as a small-cap Nasdaq issuer can put into a single filing.
The stock's reaction tells the story clearly. BTM has fallen 21% in the past week to $4.65, including a 5% drop on Tuesday alone. It has nearly doubled off its lows in a month — up 77% — but that bounce now looks like a rally into a fundamental air pocket. The speed of the reversal from the monthly high reflects how abruptly sentiment shifted when the pre-announcement landed.
Short positioning has actually been collapsing into this event, which creates a notable divergence with the fundamental backdrop. Short interest has dropped 61% over the past week to just 0.77% of the free float — a fraction of its early-May level around 15% when measured against a tighter float estimate. Borrowing costs have fallen too, from near 87% APR last week to 52% now, with availability loosening meaningfully as covered shorts return shares to the lending pool. The ORTEX short score has also pulled back sharply, falling from 82 at the start of the month to 69 as of May 12. In other words, the short community was covering aggressively as the stock rallied — and the going-concern news arrived just as that squeeze dynamic was unwinding.
The Street was caught leaning the wrong way on fundamentals. The two most recent analyst actions on record — HC Wainwright maintaining Buy at a $4.00 target and B. Riley staying Neutral at $4.20, both from mid-March — were issued before management's going-concern disclosure and the Q1 revenue collapse. Those targets now sit around the current share price, but the analytical framework that generated them did not incorporate a 49% revenue decline or restructuring risk. The EV/EBITDA multiple has compressed sharply over 30 days, falling more than 2.5 turns, consistent with a market repricing that has moved well ahead of formal analyst revisions.
Insider activity adds another layer. Founder and President/CEO Brandon Mintz sold roughly 30,000 shares on April 1 at $2.18, alongside CFO David Gray selling 7,300 shares the same day. Mintz had also sold over 1.3 million shares across October and November 2025 at prices between $2.49 and $3.49 — substantially below current levels. The insider register tells a story of consistent selling into strength across the range of prices that defined the stock's prior trading band.
Institutional ownership is heavily concentrated: Mintz himself holds 49% of shares, with Mirae Asset as the next largest institutional holder after a large reported addition of 591,000 shares. Several smaller hedge funds — LMR Partners, Aristeia Capital, and Owl Creek — appear to have built fresh positions in recent quarters. Whether those new buyers were anticipating a turnaround or are now navigating an unexpected restructuring scenario is a question the May 14 call will need to answer.
The earnings release and call scheduled for tomorrow morning are therefore less about quarterly metrics and more about what management says on the restructuring path, the litigation reserve, and whether any strategic process has advanced since the disclosure dropped.
See the live data behind this article on ORTEX.
Open BTM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.